Prescription RequiredDasatinib 50 mg (Dasatrue) is a targeted anticancer medicine used to treat certain types of leukaemia, including Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). It works by blocking abnormal proteins that promote the growth of cancer cells, helping slow disease progression and improve treatment outcomes.
| Generic name | Dasatinib |
| Strength | 50 mg |
| Manufacturer | Cipla |
| Package size | 60 Tablets |
| Used for | Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Dasatinib is a tyrosine kinase inhibitor (TKI). It blocks the BCR-ABL tyrosine kinase and other proteins responsible for the uncontrolled growth of leukaemia cells. This prevents cancer cells from multiplying and helps control the progression of the disease.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
